2021
DOI: 10.1111/bjh.17998
|View full text |Cite
|
Sign up to set email alerts
|

Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Indeed, while the potential therapeutic benefits of hypoxia preconditioning are evident and have been suggested ( Li et al, 2017 ; Caricati-Neto et al, 2019 ), fine-tuning oxygen levels to trigger beneficial effects without surpassing the critical threshold is not trivial and has low practical applications. Thus, the identification of more finely tunable interventions mimicking hypoxia, such as iron chelators already used in the clinic or undergoing clinical trials ( Wijesinghe et al, 2021 ; Yang et al, 2021 ; Reddy et al, 2022 ) or modulators of downstream molecular players mediating their beneficial effects, may suggest more practicable strategies to interfere with the detrimental features associated with aging and severe hypoxia. Different phenotypic features are concurrently associated with the pro-longevity effect induced by mild doses of CoCl 2 such as reduced animals’ size and egg-lay rate, prolonged fertility period, and increased resistance to stress ( Ventura et al, 2005 ; Rea et al, 2007 ) and delayed neuromuscular decline during aging ( Maglioni et al, 2014 ), which strikingly resemble those induced by mild mitochondrial stress.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, while the potential therapeutic benefits of hypoxia preconditioning are evident and have been suggested ( Li et al, 2017 ; Caricati-Neto et al, 2019 ), fine-tuning oxygen levels to trigger beneficial effects without surpassing the critical threshold is not trivial and has low practical applications. Thus, the identification of more finely tunable interventions mimicking hypoxia, such as iron chelators already used in the clinic or undergoing clinical trials ( Wijesinghe et al, 2021 ; Yang et al, 2021 ; Reddy et al, 2022 ) or modulators of downstream molecular players mediating their beneficial effects, may suggest more practicable strategies to interfere with the detrimental features associated with aging and severe hypoxia. Different phenotypic features are concurrently associated with the pro-longevity effect induced by mild doses of CoCl 2 such as reduced animals’ size and egg-lay rate, prolonged fertility period, and increased resistance to stress ( Ventura et al, 2005 ; Rea et al, 2007 ) and delayed neuromuscular decline during aging ( Maglioni et al, 2014 ), which strikingly resemble those induced by mild mitochondrial stress.…”
Section: Discussionmentioning
confidence: 99%